Aqueous Outflow Facility Changes With Posture

NCT ID: NCT00571012

Last Updated: 2009-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-10-31

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intraocular pressure (IOP) varies with body position, with a significant increase occurring from the seated to the supine position. Previous research has indicated that the IOP increase cannot be explained by changes in episcleral venous pressure(blood flow leading away from the eye) alone. As well, previous research has indicated that aqueous flow rate is independent of body position. The purpose of this project was to determine if aqueous humor outflow facility varied with changes in posture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

On the day of the experiment, patients will be asked to maintain a regular schedule and normal activities. This will include avoiding excess caffeine intake, large deviations from normal sleep cycle, or exposure to pharmacologic IOP modifying agents.

Subjects will be seated in standard ophthalmologic examining chairs and reclined into the supine position in a quiet room with subdued lighting for approximately 5 minutes. Anesthesia will be achieved by instilling 3-4 drops of 0.5% proparacaine. The contralateral eye will be patched in an air-tight fashion with an adhesive eye patch to reduce evaporative losses and drying of the cornea. The patient will be asked to keep eyes closed prior to start of measurements. When ready, the patient will be asked to open their eyes and to observe a dim fixation target that will be placed on the ceiling of the room, roughly 6 feet from the patient's eyes. Baseline IOP (Po) will be measured using a pneumatonometer (Model 30 Classic Mentor). Tonography will then be performed using the electronic Schiotz tonometer with a 10g weight in order to obtain a four minute tracing. The procedure will then be repeated on the contralateral eye, with patching of the already tested eye. After this, the patient's chair will the be raised 70 degrees and patient will be asked to hyperextend their neck until their cornea is parallel to the floor. A minimum of 30 minutes will be allowed to elapse, allowing for autonomic, postural and hormonal changes to stabilize. Then a repeat baseline IOP for the sitting position will be taken and another 4 minute tracing will be collected successively in each eye as described above.

Data from the tonometer tracing will be collected electronically and will be exported to a standard Excel file. A smooth curve of best fit will be established through each tonogram once graphed, correcting for oscillations and drift. This curve will help determine the adequacy of the collected sample. Tracings that have a poorly fitted curve might occur for a variety of reasons including patient tenseness and anxiety, uncontrollable tendency to fall asleep and incidental interruptions such as a sudden wave of intestinal peristalsis. Corresponding "Po" values for the initial steady-state IOP and the "C" value for facility of aqueous outflow will be gathered by referring to standard tables and normograms.

The main potential risk of participating in the study is the possibility of corneal abrasion. Previous studies at the Mayo Clinic using the same techniques did not result in any corneal abrasions in over 300 eyes of more than 150 patients. Based on this result, we estimate the risk of a corneal abrasion to be minimal. If a corneal abrasion occurs, the patient will be removed from the study. The patient will be treated with antibiotic drops or ointment and followed until the abrasion has completely healed.

Other minor risks include possible allergic reaction to the anesthetic drops or the adhesive glue. As with any medication, allergic reactions are a possibility. However, these will be the same drops used in routine clinical practice, and allergic reaction is extremely uncommon.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

glaucoma outflow facility Healthy eye function

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Only one group- A

Healthy young subjects aged 18-45.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy, aged 18-45.
* Subjects will be given a complete dilated eye exam and an updated medical history will be performed

Exclusion Criteria

* IOP greater than 22mmHg
* Evidence of glaucomatous optic neuropathy
* Poor fixation
* Nystagmus
* Tropias
* Phorias
* Recent infection
* Corneal scarring preventing reliable tonometry
* Evidence of pigment dispersion
* Narrow angles
* History of trauma or surgery
* Systemic use of beta blockers or steroids
* Diabetic eye disease, uveitis, high (\>6D) myopia or high(\>4D) hyperopia.
* Patients with chronic medical conditions(eg: hypertension) will be allowed to participate as long as their medical condition has been under good control over the preceding 12 months.
* Subjects will also need to have good cervical neck malleability and be able to meet the physical needs of the protocol which call for 4 minutes of neck extension.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mayo Clinic

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Deepan Selvadurai, MD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

GALIN MA, McIVOR JW, MAGRUDER GB. Influence of position on intraocular pressure. Am J Ophthalmol. 1963 Apr;55:720-3. No abstract available.

Reference Type BACKGROUND
PMID: 13960329 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07-006662

Identifier Type: -

Identifier Source: org_study_id